Vascular Therapeutics' Unattributed VC - II Round

Vascular Therapeutics raised a round of funding on July 24, 1998.

Biopharmaceuticals for the prevention and treatment of vascular disease. Acquired by GlycoDesign, since acquired by Inflazyme…

Articles about Vascular Therapeutics' Unattributed VC - II Round: